PI3K/Akt signaling pathway involved in regulation of T lymphocyte activation and apoptosis mediated by CD3ε

被引:1
作者
Zhang, J [1 ]
Liu, YX [1 ]
Liu, SL [1 ]
Zheng, DX [1 ]
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
来源
CHINESE SCIENCE BULLETIN | 2001年 / 46卷 / 07期
基金
中国国家自然科学基金;
关键词
apoptosis; CD8 epsilon chimera; T lymphocyte; PI3K; Akt;
D O I
10.1007/BF02900411
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To study the expression and kinase activity of phosphatidylinositol 3 ' -kinase (PI3K) and protein kinase B (PKB or Akt) during activation and apoptosis of human Jurkat T lymphocytes (TJK) with stable expression of CD8 epsilon chimera fused human CD8 alpha extracellular and transmembrane domains to intracellular domain of mouse CD3 epsilon, Western blot, kinase activities detection and immunoprecipitation were carried out. It was shown that Jurkat cells with expression of wild type chimera CD8 epsilon died by apoptosis after continuous stimulation of anti-CD8 monoclonal antibody. The expressions of PI3K and Akt, and the kinase activity of Akt remarkably increased during the process, However, this phenomenon did not occur in the Jurkat cells (T1JK) with expression of the mutant of CD8 epsilon chimera (Y170F), suggesting that PI3K/Akt signaling pathway is involved in activation and apoptosis of T lymphocyte mediated by CD3 epsilon.
引用
收藏
页码:568 / 570
页数:3
相关论文
共 50 条
  • [21] Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro
    Liu, Jia-Jun
    Liu, Wen-Da
    Yang, Hong-Zhi
    Zhang, Yong
    Fang, Zhi-Gang
    Liu, Pei-Qing
    Lin, Dong-Jun
    Xiao, Ruo-Zhi
    Hu, Yuan
    Wang, Chun-Zhi
    Li, Xu-Dong
    He, Yi
    Huang, Ren-Wei
    ANNALS OF HEMATOLOGY, 2010, 89 (11) : 1089 - 1097
  • [22] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [23] PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review
    Rajendran, Peramaiyan
    Sekar, Ramya
    Dhayasankar, Prabhu Shankar
    Ali, Enas M.
    Abdelsalam, Salaheldin Abdelraouf
    Balaraman, Sabarinath
    Chellappan, Biju Vadakkemukadiyil
    Metwally, Ashraf M.
    Abdallah, Basem M.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (06): : 1165 - 1175
  • [24] The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
    Iranpanah, Amin
    Kooshki, Leila
    Moradi, Seyed Zachariah
    Saso, Luciano
    Fakhri, Sajad
    Khan, Haroon
    PHARMACEUTICS, 2023, 15 (03)
  • [25] Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
    Su, Hua
    Peng, Chao
    Liu, Yang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [26] Physalin A Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Inhibition of PI3K/Akt Signaling Pathway
    Shang, Xiang
    Chen, Zhen
    Liu, Jianxiong
    Xu, Shuguo
    Li, Longbiao
    Yang, Zhihong
    Cui, Yuansheng
    Ruan, Pingzhao
    Peng, Xiaolan
    BIOCHEMICAL GENETICS, 2024, 62 (02) : 633 - 644
  • [27] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3
  • [28] TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
    Fan, Ming-De
    Zhao, Xue-Ying
    Qi, Jian-Ni
    Jiang, Yang
    Liu, Bing-Yu
    Dun, Zhi-Ping
    Zhang, Rui
    Wang, Cheng-Wei
    Pang, Qi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 802 - 809
  • [29] The cytotoxicity of karanjin toward breast cancer cells is involved in the PI3K/Akt signaling pathway
    Yu, Jinsong
    Yang, Han
    Lv, Chunliu
    Dai, Xiaowei
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (07) : 1673 - 1682
  • [30] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192